Faculty of 1000 Biology | Faculty member: Jay Berzofsky

About F1000

What is F1000 Biology?
Key features
How it's organized
FAQs
Faculties and sections
Scope of sections
List of Faculty Members
The evaluation system
Citing F1000
Take a tour of the site
Accessing fulltexts
PubMed linkout
How to subscribe
Academic subscriptions
Corporate subscriptions
Try F1000 for free
Who we are
Media information
Librarian resources
Press releases
In the press
Developing countries
F1000 Medicine
Terms and conditions
Privacy policy
Contact us

	Jay Berzofsky Center for Cancer Research, National Cancer Institute, United States of America
	Faculty Member: Pharmacology & Drug Discovery > Cancer Therapeutics [ since 29 August 2006 ]

[ Evaluations ]

email [Help]

Evaluations

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.
Yang L, Anderson DE, …, Kuchroo VK, Hafler DA
Nature 2008 Jul 17 454(7202):350-2 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Mohamed Sayegh with Jessamyn Bagley / Jay Berzofsky
Evaluated 6 Aug 2008

ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.
Ishikawa K, Takenaga K, …, Honma Y, Hayashi J
Science 2008 May 2 320(5876):661-4 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Jay Berzofsky
Evaluated 16 May 2008

Adaptive immunity maintains occult cancer in an equilibrium state.
Koebel CM, Vermi W, …, Smyth MJ, Schreiber RD
Nature 2007 Dec 6 450(7171):903-7 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Caetano Reis e Sousa / Glenn Dranoff / Jay Berzofsky
Evaluated 7 Jan 2008

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
McGeachy MJ, Bak-Jensen KS, …, McClanahan T, Cua DJ
Nat Immunol 2007 Dec 8(12):1390-7 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Jay Berzofsky / Brigitte Huber
Evaluated 10 Dec 2007

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V, Cekic C, …, Casella CR, Mitchell TC
Science 2007 Jun 15 316(5831):1628-32 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Rino Rappuoli / Jay Berzofsky
Evaluated 13 Jul 2007

Mast cells are essential intermediaries in regulatory T-cell tolerance.
Lu LF, Lind EF, …, Zheng XX, Noelle RJ
Nature 2006 Aug 31 442(7106):997-1002 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Stephen Cobbold / Marie Kosco-Vilbois / Marsha Wills-Karp / Yutaka Tagaya / Dan Conrad / Jay Berzofsky / Richard Grencis
Evaluated 9 Nov 2006

IL-23 promotes tumour incidence and growth.
Langowski JL, Zhang X, …, Kastelein RA, Oft M
Nature 2006 Jul 27 442(7101):461-5 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Glenn Dranoff / Torben Lund / Mark Smyth / Marie Kosco-Vilbois / Lieping Chen / Arthur Hurwitz / Andrew Weinberg / Jay Berzofsky
Evaluated 15 Sep 2006

^Top Back to Faculty Members